Moreover, several studies also revealed the antiangiogenic action of ZLM-7 in breast cancer by blocking the vascular endothelial growth factor (VEGF) singling in xenograft mouse models [10,11], suggesting that ZLM-7 could be a promising compound for the inhibition of breast carcinoma. The gene discussed is VEGFA; the disease is breast carcinoma.